Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Njuguna, Christine Wanjiku
Other Authors: Cox, Helen
Format: Thesis
Language:English
Published: Department of Public Health and Family Medicine 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613148780953600
access_status_str Open Access
author Njuguna, Christine Wanjiku
author2 Cox, Helen
author_browse Cox, Helen
Njuguna, Christine Wanjiku
author_facet Cox, Helen
Njuguna, Christine Wanjiku
author_sort Njuguna, Christine Wanjiku
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/10625
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:31:31.816Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Public Health and Family Medicine
publisherStr Department of Public Health and Family Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/10625 Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa Njuguna, Christine Wanjiku Cox, Helen Boulle, Andrew Epidemiology Includes bibliographical references. Treatment for drug-resistant tuberculosis (DR-TB) is longer and associated with more significant side-effects than drug susceptible TB. Second line injectable therapy using kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. There is a scarcity of literature regarding the frequency of hearing loss as well as associated risk factors, particularly with long term use. This study aimed to determine the incidence and risk factors for hearing loss among patients receiving second line injectable drugs. 2014-12-30T19:49:26Z 2014-12-30T19:49:26Z 2013 Master Thesis Masters MPH http://hdl.handle.net/11427/10625 eng application/pdf Department of Public Health and Family Medicine Faculty of Health Sciences University of Cape Town
spellingShingle Epidemiology
Njuguna, Christine Wanjiku
Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
thesis_degree_str Master's
title Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_full Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_fullStr Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_full_unstemmed Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_short Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
title_sort baseline prevalence and incidence and risk factors for new onset drug induced hearing loss in adults receiving drug resistant tuberculosis dr tb treatment in khayelitsha south africa
topic Epidemiology
url http://hdl.handle.net/11427/10625
work_keys_str_mv AT njugunachristinewanjiku baselineprevalenceandincidenceandriskfactorsfornewonsetdruginducedhearinglossinadultsreceivingdrugresistanttuberculosisdrtbtreatmentinkhayelitshasouthafrica